# Epigenetics and NCD Prevention in Kazakhstan: Personalized Approaches and Biological Age Prediction

> **NCT06953180** · — · RECRUITING · sponsor: **Asfendiyarov Kazakh National Medical University** · enrollment: 6720 (estimated)

## Conditions studied

- Cardiovascular Diseases (CVD)
- Type 2 Diabetes
- Chronic Respiratory Diseases
- Obesity (Disorder)
- Chronic Kidney Diseases

## Interventions

- **OTHER:** Genetic: DNA analysis

## Key facts

- **NCT ID:** NCT06953180
- **Lead sponsor:** Asfendiyarov Kazakh National Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-03
- **Primary completion:** 2026-01-01
- **Final completion:** 2026-12-31
- **Target enrollment:** 6720 (ESTIMATED)
- **Last updated:** 2025-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06953180

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06953180, "Epigenetics and NCD Prevention in Kazakhstan: Personalized Approaches and Biological Age Prediction". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06953180. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*